Katarina Lindemann

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
182 Background: TMRSS2-ERG fusion is the most frequent genetic abberation in prostate cancer. Till now its expression is not associated with a poorer prognosis. In cell line models the fusion can be induced by exogenic factors as hormonal treatment or radiotherapy. Additionally its expression leads to different sensitivities to radiotherapy in different(More)
  • 1